This inventor holds 1 USPTO granted patent. Top assignee: Machavert Pharmaceuticals LLC. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Zbončáková Milada: Innovator in Anti-Cancer Compositions
Introduction
Zbončáková Milada is a notable inventor based in Lovosice, Czech Republic. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-cancer agents. His innovative work focuses on utilizing modified egg yolk extracts to combat cancerous cell growth.
Latest Patents
Milada holds a patent for phospholipid compositions that involve a modified egg yolk extract. This patent describes compositions that are effective as anti-cancer agents. The modified egg yolk extract includes specific fractions of phosphatidylcholines and sphingomyelins, which are produced through chemical synthesis. These modifications have been shown to inhibit the growth of cancerous cells effectively. The patent also outlines various methods for administering these compositions.
Career Highlights
Milada is associated with Machavert Pharmaceuticals LLC, where he continues to advance his research and development efforts. His work has garnered attention for its potential impact on cancer treatment and prevention.
Collaborations
Milada collaborates with notable colleagues, including Jakub D Staszak-Jirkovsky and Lukas Kobr. Their combined expertise contributes to the innovative research being conducted at Machavert Pharmaceuticals LLC.
Conclusion
Zbončáková Milada's contributions to the field of anti-cancer research through his patented phospholipid compositions highlight his role as an influential inventor. His work promises to pave the way for new therapeutic options in cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile